<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35027428</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001056</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2021-001056</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The impact of acute COVID-19 on people with asthma appears complex, being moderated by multiple interacting disease-specific, demographic and environmental factors. Research regarding longer-term effects in this group is limited. We aimed to assess impacts of COVID-19 and predictors of persistent symptoms, in people with asthma.</AbstractText><AbstractText Label="METHODS">Using data from an online UK-wide survey of 4500 people with asthma (median age 50-59 years, 81% female), conducted in October 2020, we undertook a mixed methods analysis of the characteristics and experience of those reporting having had COVID-19.</AbstractText><AbstractText Label="RESULTS">The COVID-19 group (n=471, 10.5%) reported increased inhaler use and worse asthma management, compared with those not reporting COVID-19, but did not differ by gender, ethnicity or household income. Among the COVID-19 group, 56.1% reported having long COVID, 20.2% were 'unsure'. Those with long COVID were more likely than those without long COVID to describe: their breathing as worse or much worse after their initial illness (73.7% vs 34.8%, p&lt;0.001), increased inhaler use (67.8% vs 34.8%, p&lt;0.001) and worse or much worse asthma management (59.6% vs 25.6%, p&lt;0.001). Having long COVID was not associated with age, gender, ethnicity, UK nation or household income.Analysis of free text survey responses identified three key themes: (1) variable COVID-19 severity, duration and recovery; (2) symptom overlap and interaction between COVID-19 and asthma; (3) barriers to accessing healthcare.</AbstractText><AbstractText Label="CONCLUSIONS">Persisting symptoms are common in people with asthma following COVID-19. Measures are needed to ensure appropriate healthcare access including clinical evaluation and investigation, to distinguish between COVID-19 symptoms and asthma.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Keir Elmslie James</ForeName><Initials>KEJ</Initials><Identifier Source="ORCID">0000-0001-9614-3580</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK k.philip@imperial.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buttery</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Parris</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayakumar</LastName><ForeName>Bavithra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonkin</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cumella</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renwick</LastName><ForeName>Lottie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Policy and External Affairs, Asthma UK, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogden</LastName><ForeName>Lizzie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Asthma UK and British Lung Foundation Partnership, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Epidemiology, Occupational Medicine and Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Sebastian L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polkey</LastName><ForeName>Michael I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkinson</LastName><ForeName>Nicholas S</ForeName><Initials>NS</Initials><Identifier Source="ORCID">0000-0003-3235-0454</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Respiratory Biomedical Research Unit, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">asthma in primary care</Keyword><Keyword MajorTopicYN="N">respiratory infection</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35027428</ArticleId><ArticleId IdType="pmc">PMC8762134</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2021-001056</ArticleId><ArticleId IdType="pii">9/1/e001056</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnston SL, Pattemore PK, Sanderson G, et al. . Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225&#x2013;9. 10.1136/bmj.310.6989.1225</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.310.6989.1225</ArticleId><ArticleId IdType="pmc">PMC2549614</ArticleId><ArticleId IdType="pubmed">7767192</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:10.1136/bmj.307.6910.982:982&#x2013;6. 10.1136/bmj.307.6910.982</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.307.6910.982</ArticleId><ArticleId IdType="pmc">PMC1679193</ArticleId><ArticleId IdType="pubmed">8241910</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SL. Asthma and COVID-19: is asthma a risk factor for severe outcomes? Allergy 2020;75:1543&#x2013;5. 10.1111/all.14348</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14348</ArticleId><ArticleId IdType="pmc">PMC7267381</ArticleId><ArticleId IdType="pubmed">32358994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkinson NS, Jenkins G, Hart N. COVID-19 and what comes after? Thorax 2021;76:324&#x2013;5. 10.1136/thoraxjnl-2020-216226</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216226</ArticleId><ArticleId IdType="pubmed">33589513</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilev M, Kristensen KB, Potteg&#xe5;rd A, et al. . Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol 2020;49:1468&#x2013;81. 10.1093/ije/dyaa140</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa140</ArticleId><ArticleId IdType="pmc">PMC7499657</ArticleId><ArticleId IdType="pubmed">32887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochlainn MN, Lee KA, Sudre CH. Key predictors of attending hospital with COVID19: an association study from the COVID symptom Tracker APP in 2,618,948 individuals. medRxiv 2020:2020.04.25.20079251.</Citation></Reference><Reference><Citation>NIHR . Living with Covid19 &#x2013; second review 2021.</Citation></Reference><Reference><Citation>Zhu Z, Hasegawa K, Ma B, et al. . Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol 2020;146:327&#x2013;9. 10.1016/j.jaci.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7423602</ArticleId><ArticleId IdType="pubmed">32522462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunjaya AP, Allida SM, Di Tanna GL, et al. . Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis. J Asthma 2021:1&#x2013;14. 10.1080/02770903.2021.1888116</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2021.1888116</ArticleId><ArticleId IdType="pmc">PMC8022341</ArticleId><ArticleId IdType="pubmed">33556287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan S, Nicolau DV, Langford B, et al. . Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med 2021;9:10.1016/S2213-2600(21)00160-0:763&#x2013;72. 10.1016/S2213-2600(21)00160-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00160-0</ArticleId><ArticleId IdType="pmc">PMC8040526</ArticleId><ArticleId IdType="pubmed">33844996</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffler E, Detoraki A, Contoli M, et al. . COVID-19 in severe asthma network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy 2021;76:10.1111/all.14532:887&#x2013;92. 10.1111/all.14532</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14532</ArticleId><ArticleId IdType="pmc">PMC7436509</ArticleId><ArticleId IdType="pubmed">32738147</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt H, Talaei M, Greenig M, et al. . Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax 2021. 10.1136/thoraxjnl-2021-217487. [Epub ahead of print: 30 Nov 2021].</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217487</ArticleId><ArticleId IdType="pubmed">34848555</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430&#x2013;6. 10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom CI, Drake TM, Docherty AB, et al. . Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC who clinical characterisation protocol UK. Lancet Respir Med 2021;9:699&#x2013;711. 10.1016/S2213-2600(21)00013-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00013-8</ArticleId><ArticleId IdType="pmc">PMC8241313</ArticleId><ArticleId IdType="pubmed">33676593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. Nice guideline on long covid. BMJ 2020;371:m4938. 10.1136/bmj.m4938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K, Cumella A, Farrington-Douglas J, et al. . Respiratory patient experience of measures to reduce risk of COVID-19: findings from a descriptive cross-sectional UK wide survey. BMJ Open 2020;10:e040951. 10.1136/bmjopen-2020-040951</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040951</ArticleId><ArticleId IdType="pmc">PMC7482474</ArticleId><ArticleId IdType="pubmed">32912958</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KEJ, Lonergan B, Cumella A, et al. . COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study. BMC Pulm Med 2020;20:319. 10.1186/s12890-020-01363-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01363-9</ArticleId><ArticleId IdType="pmc">PMC7724437</ArticleId><ArticleId IdType="pubmed">33298023</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K, Gaduzo S, Rogers J, et al. . Patient experience of COPD care: outcomes from the British lung Foundation patient Passport. BMJ Open Respir Res 2019;6:e000478. 10.1136/bmjresp-2019-000478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2019-000478</ArticleId><ArticleId IdType="pmc">PMC6797266</ArticleId><ArticleId IdType="pubmed">31673369</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S, Philip KEJ, Williams P, et al. . Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res 2021;8:e001075. 10.1136/bmjresp-2021-001075</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001075</ArticleId><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77&#x2013;101. 10.1191/1478088706qp063oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet respiratory M . Personalised medicine for asthma in a post-pandemic world. Lancet Respir Med 2021;9:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831750</ArticleId><ArticleId IdType="pubmed">33341156</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . NICE guideline [NG188] COVID-19 rapid guideline: managing the long-term effects of COVID-19. Version 1.7, 2021.</Citation></Reference><Reference><Citation>Office for National Statistics . Coronavirus (COVID-19) infection survey, antibody data for the UK: 16 March 2021. UK Government, 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>